Nu Eyne

Seoul, South Korea Founded: 2017 • Age: 9 yrs
Medical devices using electrical stimulation for health conditions are developed.
Annual revenue $507,069 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Nu Eyne

Nu Eyne is a company based in Seoul (South Korea) founded in 2017. Nu Eyne operates in a competitive market with competitors including CorneaGen, Cellusion, EyeGate, CorNeat Vision and Avedro, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name New Ain Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $507.07 K (USD)
    590
    as on Dec 31, 2024
  • Net Profit
    $7.36 M (USD)
    221
    as on Dec 31, 2024
  • EBITDA
    $8.82 M (USD)
    338
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Nu Eyne

Headcount 1-10
Employee Profiles 7
Employee Profiles
People
Dohyoung Kim
Executive
People
Hwa Sun
Manager, Operations
People
Pyungkyu Kim
Director, Business Development
People
Léa Jégo
Marketing Internship

Unlock access to complete

Funding Insights of Nu Eyne

Premium access

Detailed funding history for Nu Eyne

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Nu Eyne

Investments
Premium access

Investment portfolio details for Nu Eyne

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Nu Eyne

Premium access

Detailed financials for Nu Eyne

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Nu Eyne Comparisons

Nu Eyne Primary company
Description
Medical devices using electrical stimulation for health cond...
Location
Seoul, South Korea
Founded Year
2017
Annual Revenue
$507.07 K (USD)
Net Profit
$7.36 M (USD)
EBITDA
$8.82 M (USD)
Employees
Not available
Premium access

Peer comparison for Nu Eyne

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Nu Eyne

Nu Eyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Cellusion, EyeGate, CorNeat Vision and Avedro, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapeutic devices for corneal transplants are developed by CorneaGen.
Locked Locked Locked
iPS cell-based technology for corneal endothelium regeneration is developed.
Locked Locked Locked
Therapeutics and drug delivery systems for eye diseases are developed.
Locked Locked Locked
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
Locked Locked Locked
Corneal collagen cross-linking technology is developed for ophthalmic applications.
Locked Locked Locked
Ophthalmic devices for corneal edema treatment are developed.
Premium access

Detailed competitors of Nu Eyne

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nu Eyne

Premium access

Complete news archive for Nu Eyne

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nu Eyne

Nu Eyne was founded in 2017.

Nu Eyne is headquartered in Seoul, South Korea.

Annual revenue of Nu Eyne is $507.07K as on Dec 31, 2024.

Nu Eyne was founded in 2017 and is located in Seoul, South Korea, within the medical devices sector. Devices are developed for treating conditions such as corneal diseases, facial nerve palsy, migraines, ADHD, and overactive bladder. Electrical stimulation is applied in these devices to induce and maintain sleep, support nerve function recovery, and regulate abnormal nervous system activities.

Nu Eyne's top competitors include CorneaGen, EyeYon and Avedro.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available